Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James W Doolin

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
BMJ Case Reports|February 6, 2023
Partial response in non-resectable adenosquamous carcinoma of the pancreas with high tumour mutation burden treated with gemcitabine, nab-paclitaxel and pembrolizumabRodrigo Paredes de la Fuente, James W Doolin, Mary Linton Peters
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 5, 2019
Why focus on patient-reported outcome measures in older colorectal cancer patients?James W Doolin, Meredith Halpin, Jonathan L Berry, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|November 26, 2009
A cluster of amyotrophic lateral sclerosis in New Hampshire: a possible role for toxic cyanobacteria bloomsTracie A Caller, James W Doolin, James F Haney, et al.
Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality|July 24, 2025
Using Quality Improvement and Implementation Science to Identify Strategies That Foster Electronic Patient-Reported Outcome SubmissionsJames W Doolin, Samira L Dias, Christine Cronin, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
BMJ Case Reports|February 6, 2023
Partial response in non-resectable adenosquamous carcinoma of the pancreas with high tumour mutation burden treated with gemcitabine, nab-paclitaxel and pembrolizumabRodrigo Paredes de la Fuente, James W Doolin, Mary Linton Peters
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 5, 2019
Why focus on patient-reported outcome measures in older colorectal cancer patients?James W Doolin, Meredith Halpin, Jonathan L Berry, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|November 26, 2009
A cluster of amyotrophic lateral sclerosis in New Hampshire: a possible role for toxic cyanobacteria bloomsTracie A Caller, James W Doolin, James F Haney, et al.
Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality|July 24, 2025
Using Quality Improvement and Implementation Science to Identify Strategies That Foster Electronic Patient-Reported Outcome SubmissionsJames W Doolin, Samira L Dias, Christine Cronin, et al.
Pageof 1